Acceleron Pharma reported $34.2M in Sales Revenues for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Abbvie ABBV:US $ 14342M 383M
Acceleron Pharma XLRN:US $ 34.2M 6.26M
Akebia Therapeutics AKBA:US $ 48.76M 4.16M
Alexion Pharmaceuticals ALXN:US $ 1636.5M 44.7M
Amgen AMGN:US $ 6706M 180M
Arena Pharmaceuticals ARNA:US $ 0M 0M
Bayer BAYN:GR € 9781M 1073M
Biomarin Pharmaceutical BMRN:US $ 408.74M 92.95M
Bluebird Bio BLUE:US $ 22.68M 15.2M
Clovis Oncology CLVS:US $ 37.92M 1.1M
Dicerna Pharmaceuticals DRNA:US $ 62.95M 21.62M
Eli Lilly And LLY:US $ 6772.8M 32.7M
Exelixis EXEL:US $ 328.42M 56.75M
Gilead Sciences GILD:US $ 7421M 1204M
GlaxoSmithKline GSK:LN 9077M 985M
Johnson & Johnson JNJ:US $ 23338M 26M
Karyopharm Therapeutics KPTI:US $ 37.69M 15.09M
Mirati Therapeutics MRTX:US $ 71.79M 71.79M
Neurocrine Biosciences NBIX:US $ 296M 7.1M
Novartis NOVN:VX SF 13367M 73M
Pfizer PFE:US $ 24094M 5117M
Ptc Therapeutics PTCT:US $ 138.74M 22.07M
Puma Biotechnology PBYI:US $ 46.24M 7.14M
Regeneron Pharmaceuticals REGN:US $ 3452.8M 1685.7M
Rigel Pharmaceuticals RIGL:US $ 21.54M 4.72M
Sangamo Biosciences SGMO:US $ 28.56M 0.69M
Tg Therapeutics TGTX:US $ 2.03M 0.48M
Ultragenyx Pharmaceutical RARE:US $ 81.65M 5.33M
United Therapeutics UTHR:US $ 444.7M 1.8M
Vertex Pharmaceuticals VRTX:US $ 1984.16M 190.79M